Company Filing History:
Years Active: 2002-2007
Title: Innovator in Pharmacology: Richard R. Schartman
Introduction
Richard R. Schartman, an accomplished inventor based in Evanston, IL, has made significant contributions to the field of pharmacology through his innovative work. With a total of five patents to his name, Schartman's pioneering research has focused on compounds that play a crucial role in medical therapies.
Latest Patents
Among his notable inventions is a patent for amidino compounds useful as nitric oxide synthase inhibitors. This invention pertains to amidino compounds, their salts, and prodrugs, which can be utilized therapeutically, particularly in inhibiting nitric oxide synthase. Additionally, he has developed methods for producing these amidino compounds, specifically targeting alpha-amino acid compounds through hydrolyzing conditions involving hydantoin compounds.
Career Highlights
Richard R. Schartman's career is prominently linked with his work at Pharmacia Corporation, where he has contributed his expertise in medicinal chemistry. His innovative approaches have addressed various therapeutic needs, particularly in enhancing nitric oxide synthase inhibition mechanisms.
Collaborations
Throughout his career, Schartman has collaborated with esteemed colleagues, including Ronald Keith Webber and Richard C. Durley. Together, they have advanced research initiatives, fostering a collaborative environment that enhances the discovery of novel therapeutic applications.
Conclusion
Richard R. Schartman's contributions to pharmacology underscore the importance of innovation in developing effective therapies. His patents and collaborative efforts exemplify how dedicated inventors can impact healthcare positively, paving the way for future advancements in medicine.